Methylene blue improves sensorimotor phenotype and decreases anxiety in parallel with activating brain mitochondria biogenesis in mid-age mice
Age-related brain dysfunctions are associated with mitochondria malfunctions and increased risk of developing neurodegenerative diseases (ND). Recently, a mitochondria-targeting drug methylene blue has been drawing considerable interest as a potential treatment for ND. We found that aged mice manifested a decrease in physical endurance, spontaneous locomotor activity, and exploration concomitant with an increase in anxiety-related behavior, as compared to adult mice. Treating mice for 60 days with MB slowed down these changes. There were no significant changes in the animals' body weight, oxygen consumption rates, or respiratory quotient index, in adult or aged MB-treated mice. However, MB treatment significantly increased the generation of reactive oxygen species in brain mitochondria. The expression of several genes relevant to mitochondria biogenesis, bioenergetics, and antioxidant defense (NRF1, MTCOX1, TFAM, and SOD2) was greatly suppressed in aged mice; it was restored by MB treatment. It seems plausible that the effects of MB could be mediated by its ability to increase H2O2 production in brain mitochondria, thereby activating Nrf2/ARE signaling pathway and mitochondria biogenesis. Our data and earlier findings support the idea that MB can be an attractive prototype drug for developing safe and efficient gerontoprotective compounds.
Keywords: Aging; Behavior; Hydrogen peroxide; Methylene blue; Mitochondria.
Copyright Â© 2016 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.
Enhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria.Free Radic Biol Med. 2014 Dec;77:317-30. doi: 10.1016/j.freeradbiomed.2014.09.024. Epub 2014 Sep 30. Free Radic Biol Med. 2014. PMID: 25277417
Mitigation of carbon tetrachloride-induced hepatic injury by methylene blue, a repurposed drug, is mediated by dual inhibition of GSK3β downstream of PKA.Br J Pharmacol. 2014 Jun;171(11):2790-802. doi: 10.1111/bph.12637. Br J Pharmacol. 2014. PMID: 24641162 Free PMC article.
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.Hum Mol Genet. 2014 Jul 15;23(14):3716-32. doi: 10.1093/hmg/ddu080. Epub 2014 Feb 20. Hum Mol Genet. 2014. PMID: 24556215 Free PMC article.
Methylene blue does not bypass Complex III antimycin block in mouse brain mitochondria.FEBS Lett. 2019 Mar;593(5):499-503. doi: 10.1002/1873-3468.13332. Epub 2019 Feb 20. FEBS Lett. 2019. PMID: 30734287 Free PMC article.
Effects of transcranial photobiomodulation and methylene blue on biochemical and behavioral profiles in mice stress model.Lasers Med Sci. 2020 Apr;35(3):573-584. doi: 10.1007/s10103-019-02851-z. Epub 2019 Aug 1. Lasers Med Sci. 2020. PMID: 31372913
Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?Neurochem Int. 2017 Oct;109:117-125. doi: 10.1016/j.neuint.2017.04.004. Epub 2017 Apr 7. Neurochem Int. 2017. PMID: 28396091 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources